Tag Archives: Dr. Pierre Guertin

Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands

QUEBEC CITY, CANADA, October 10th 2019 – Today, Laboratoires Guertin announces that a campaign for funding has been launched to support a phase IIb-enabling pilot study with a tritherapy candidate (buspirone/L-DOPA/carbidopa)called Spinalon. This experimental oral pill has been shown to … Continue reading

Posted in Chronic Spinal Cord Injury Research, Neuromodulation, Rehabilitation, spinal cord injury research | Tagged | 6 Comments

Nordic Life Science completes first trial of it’s Spinalon™ pill for chronic paralysis

Press Release: Nordic Life Science Pipeline Inc. “Nordic” is proud to announce completion of the first clinical trials of SpinalonTM, an oral pill composed of three active molecular entities capable together of triggering within minutes short bouts of locomotor-like activity … Continue reading

Posted in Chronic Spinal Cord Injury Research, Rehabilitation, spinal cord injury research | Tagged , | 15 Comments